• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱尿路上皮癌的临床、人口统计学和组织病理学预后因素

Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder.

作者信息

Kucuk Ulku, Pala Emel Ebru, Cakır Ebru, Sezer Ozlem, Bayol Umit, Divrik Rauf Taner, Cakmak Ozgur

机构信息

Izmir Tepecik Research and Training Hospital, Department of Pathology, Izmir, Turkey.

Sifa Universitiy Medical Faculty, Department of Urology, Izmir, Turkey.

出版信息

Cent European J Urol. 2015;68(1):30-6. doi: 10.5173/ceju.2015.01.465. Epub 2015 Mar 13.

DOI:10.5173/ceju.2015.01.465
PMID:25914835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4408388/
Abstract

INTRODUCTION

Our aim is to evaluate the influence of clinical and histopathological parameters, including age, gender, tumor stage, grade, tumor differentiation, necrosis, lymphovascular/perineural invasion (LVI/PNI) and concomitant carcinoma in situ (CIS), on outcomes of patients with urothelial carcinoma of the bladder (UCB).

MATERIAL AND METHODS

A total of 84 patients who underwent radical cystectomy (RC) (n = 11) and radical cystoprostatectomy (n = 73) for muscle-invasive bladder cancer at our hospital between 2007-2013, were included in the study.

RESULTS

The mean age of patients at diagnosis was 66.1, of whom 75 were males and 9 were females. Of the 84 patients, 38 were ≤65 years and 46 were >65 years. Mean tumor diameter was 3.66 cm. There were 38 cases which showed divergent differentiations. Concomitant CIS was observed in 30 tumors, 41 cases showed tumor necrosis, 44 PNI and 61 LVI. The rate of overall survival (OS) in patients aged ≤65 years was statistically significantly higher than in those aged >65 years. A negative statistical relationship was found between OS with lymph node metastasis (LNM) and tumor differentiation. On the other hand, necrosis did not remain significant on multivariate analysis. No statistically significant relationship was found between smoking, tumor stage, PNI, LVI and concomitant CIS and OS.

CONCLUSIONS

In this study, advanced age, LNM, tumor differentiation were found to be independent prognostic risk factors associated with OS after RC. These additional factors, which may explain the different clinical course in patients with similar tumor stage and lymph node status, should be taken into consideration in treatment planning.

摘要

引言

我们的目的是评估临床和组织病理学参数,包括年龄、性别、肿瘤分期、分级、肿瘤分化、坏死、淋巴管/神经周围浸润(LVI/PNI)和原位癌(CIS)对膀胱尿路上皮癌(UCB)患者预后的影响。

材料与方法

2007年至2013年期间在我院因肌层浸润性膀胱癌接受根治性膀胱切除术(RC)(n = 11)和根治性膀胱前列腺切除术(n = 73)的84例患者纳入本研究。

结果

患者诊断时的平均年龄为66.1岁,其中男性75例,女性9例。84例患者中,38例年龄≤65岁,46例年龄>65岁。平均肿瘤直径为3.66 cm。有38例显示出不同程度的分化。30个肿瘤中观察到合并原位癌,41例显示肿瘤坏死,44例有神经周围浸润,61例有淋巴管浸润。年龄≤65岁患者的总生存率(OS)在统计学上显著高于年龄>65岁的患者。总生存率与淋巴结转移(LNM)和肿瘤分化之间存在负相关的统计学关系。另一方面,在多变量分析中,坏死不再具有显著性。吸烟、肿瘤分期、神经周围浸润、淋巴管浸润和合并原位癌与总生存率之间未发现统计学上的显著关系。

结论

在本研究中,发现高龄、淋巴结转移、肿瘤分化是与根治性膀胱切除术后总生存率相关的独立预后危险因素。这些可能解释具有相似肿瘤分期和淋巴结状态患者不同临床病程的额外因素,在治疗计划中应予以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0281/4408388/d4a45ed46592/CEJU-68-00465-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0281/4408388/52a7b915288f/CEJU-68-00465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0281/4408388/7c9d1b4b430f/CEJU-68-00465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0281/4408388/7d7370fdfac4/CEJU-68-00465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0281/4408388/d4a45ed46592/CEJU-68-00465-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0281/4408388/52a7b915288f/CEJU-68-00465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0281/4408388/7c9d1b4b430f/CEJU-68-00465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0281/4408388/7d7370fdfac4/CEJU-68-00465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0281/4408388/d4a45ed46592/CEJU-68-00465-g004.jpg

相似文献

1
Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder.膀胱尿路上皮癌的临床、人口统计学和组织病理学预后因素
Cent European J Urol. 2015;68(1):30-6. doi: 10.5173/ceju.2015.01.465. Epub 2015 Mar 13.
2
Prognostic significance of tumor budding in muscle invasive urothelial carcinomas of the bladder.肿瘤芽生在膀胱肌层浸润性尿路上皮癌中的预后意义
Turk J Urol. 2018 Aug 31;45(4):273-278. doi: 10.5152/tud.2018.58269. Print 2019 Jul.
3
Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.评估 CD10 表达水平及其对埃及膀胱癌患者的预后影响。
Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1573-1583. doi: 10.31557/APJCP.2020.21.6.1573.
4
Clinicopathological prognostic factors for upper tract urothelial carcinoma.上尿路尿路上皮癌的临床病理预后因素
Cent European J Urol. 2016;69(1):57-62. doi: 10.5173/ceju.2016.713. Epub 2016 Feb 26.
5
Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder.淋巴管浸润与膀胱鳞状细胞癌根治性膀胱切除术后的肿瘤学预后相关。
Urol Oncol. 2016 Sep;34(9):417.e1-8. doi: 10.1016/j.urolonc.2016.03.023. Epub 2016 May 3.
6
Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.根治性膀胱切除术后肌层浸润性尿路上皮膀胱癌的结局
Clin Genitourin Cancer. 2016 Feb;14(1):e43-7. doi: 10.1016/j.clgc.2015.07.007. Epub 2015 Aug 6.
7
Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.根治性膀胱切除术后癌症特异性生存率和围手术期死亡率的性别差异分析:一项对近2500例膀胱尿路上皮癌患者进行的大型德国多中心研究结果
Gend Med. 2012 Dec;9(6):481-9. doi: 10.1016/j.genm.2012.11.001.
8
Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.根治性膀胱切除术后膀胱尿路上皮癌中淋巴管生成和增殖标志物mRNA水平的预测价值
Urol Oncol. 2018 Dec;36(12):530.e19-530.e27. doi: 10.1016/j.urolonc.2018.09.003. Epub 2018 Nov 13.
9
The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.肿瘤直径和肿瘤坏死对接受根治性膀胱切除术治疗的膀胱尿路上皮癌患者肿瘤学结局的影响。
Urology. 2015 Jul;86(1):92-8. doi: 10.1016/j.urology.2015.03.036. Epub 2015 Jun 4.
10
Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.根治性膀胱切除术后埃及大单一中心队列中不同组织病理学类型膀胱癌的病理特征和预后指标。
World J Urol. 2018 Nov;36(11):1835-1843. doi: 10.1007/s00345-018-2331-6. Epub 2018 May 14.

引用本文的文献

1
Do Fibroblast Growth Factor Receptor (FGFR) 2 and 3 Proteins Play a Role in Prognosis of Invasive Urothelial Bladder Carcinoma?成纤维细胞生长因子受体(FGFR)2和3蛋白在浸润性膀胱尿路上皮癌的预后中起作用吗?
Iran J Pathol. 2024 Winter;19(1):81-88. doi: 10.30699/IJP.2024.2012115.3180. Epub 2024 Mar 29.
2
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort.雅努斯血清库队列中膀胱癌患者诊断前血清25-羟维生素D水平与死亡率
Clin Epidemiol. 2021 Sep 14;13:801-811. doi: 10.2147/CLEP.S319620. eCollection 2021.
3
Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.

本文引用的文献

1
Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series.荷兰某大学医院行根治性膀胱切除术:单纯手术系列中一致的长期结果和预后因素。
Clin Genitourin Cancer. 2014 Jun;12(3):190-5. doi: 10.1016/j.clgc.2013.11.004. Epub 2013 Nov 12.
2
Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.膀胱尿路上皮癌在膀胱切除标本中出现鳞状和腺性分化是否预示预后不良?一项深入的病例对照分析。
Urol Oncol. 2014 Feb;32(2):117-27. doi: 10.1016/j.urolonc.2012.08.017. Epub 2013 Mar 7.
3
膀胱癌中 PHGDH 表达的特征:吉西他滨/顺铂的潜在靶向治疗及启动子 DNA 低甲基化的作用。
Mol Oncol. 2020 Sep;14(9):2190-2202. doi: 10.1002/1878-0261.12697. Epub 2020 Jun 20.
4
Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study.c-Myc免疫组化表达在膀胱肌层浸润性尿路上皮癌中的预后价值:一项回顾性研究
Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3735-3746. doi: 10.31557/APJCP.2019.20.12.3735.
5
8-armed octopus: Evaluation of clinicopathologic prognostic factors of urothelial carcinoma of the upper urinary system.八腕章鱼:上泌尿道尿路上皮癌的临床病理预后因素评估。
Turk J Med Sci. 2019 Feb 11;49(1):153-161. doi: 10.3906/sag-1805-51.
6
Prognostic significance of tumor budding in muscle invasive urothelial carcinomas of the bladder.肿瘤芽生在膀胱肌层浸润性尿路上皮癌中的预后意义
Turk J Urol. 2018 Aug 31;45(4):273-278. doi: 10.5152/tud.2018.58269. Print 2019 Jul.
7
Bladder Preservation for Muscle Invasive Bladder Cancer.肌肉浸润性膀胱癌的膀胱保留术
Bladder Cancer. 2016 Apr 27;2(2):151-163. doi: 10.3233/BLC-150025.
8
Impact of stage and comorbidities on five-year survival after radical cystectomy in Poland: single centre experience.分期和合并症对波兰根治性膀胱切除术后五年生存率的影响:单中心经验
Cent European J Urol. 2015;68(3):278-83. doi: 10.5173/ceju.2015.620. Epub 2015 Oct 15.
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
根治性膀胱切除术治疗膀胱癌患者的组织学亚型对肿瘤学结局的影响。
Eur J Cancer. 2013 May;49(8):1889-97. doi: 10.1016/j.ejca.2013.02.001. Epub 2013 Mar 4.
4
Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.根治性膀胱切除术后癌症特异性生存率和围手术期死亡率的性别差异分析:一项对近2500例膀胱尿路上皮癌患者进行的大型德国多中心研究结果
Gend Med. 2012 Dec;9(6):481-9. doi: 10.1016/j.genm.2012.11.001.
5
Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.吸烟和戒烟对接受根治性膀胱切除术的膀胱癌患者结局的影响。
Eur Urol. 2013 Sep;64(3):456-64. doi: 10.1016/j.eururo.2012.11.039. Epub 2012 Nov 27.
6
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.在病理肿瘤分期 T4a 的膀胱癌患者中,根治性膀胱切除术治疗后的癌症特异性生存的性别特异性差异。
Urol Oncol. 2013 Oct;31(7):1141-7. doi: 10.1016/j.urolonc.2011.09.011. Epub 2011 Nov 6.
7
Gender-dependent cancer-specific survival following radical cystectomy.根治性膀胱切除术治疗后的性别相关癌症特异性生存。
World J Urol. 2012 Oct;30(5):707-13. doi: 10.1007/s00345-011-0773-1. Epub 2011 Oct 9.
8
Association between smoking and risk of bladder cancer among men and women.吸烟与男性和女性膀胱癌风险的关联。
JAMA. 2011 Aug 17;306(7):737-45. doi: 10.1001/jama.2011.1142.
9
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.膀胱切除标本中伴发的原位癌与术后临床结局无关。
Urol Int. 2011;87(1):42-8. doi: 10.1159/000325463. Epub 2011 Jun 9.
10
Impact of gender on bladder cancer incidence, staging, and prognosis.性别对膀胱癌发病率、分期和预后的影响。
World J Urol. 2011 Aug;29(4):457-63. doi: 10.1007/s00345-011-0709-9. Epub 2011 Jun 9.